哮喘-慢阻肺重叠之中医病名初探

Study on Disease Name of Asthma-Chronic Obstructive Pulmonary Overlap in Traditional Chinese Medicine

哮喘和慢阻肺并存的患者临床上并不少见,哮喘-慢阻肺重叠（ACO）是2017全球哮喘防治创议（GINA）更新版中提出的新术语,然中医学上尚未有与之对应的中医病名。通过对哮喘-慢阻肺重叠中医病因、病机、病名的初步探讨,认为本病病因病机特点为哮喘反复发作,久病肺虚,多种病理因素的共同作用下,终致肺气胀满,不能敛降。通过分析古代文献中对“哮喘”“慢阻肺”“哮喘-慢阻肺重叠”相应病名的描述,建议性地提出将哮喘-慢阻肺重叠归入“哮胀”为妥。

It is not uncommon for patients with asthma and chronic obstructive pulmonary disease to co-ex- ist. Asthma-chronic obstructive pulmonary overlap （ACO） is a new term introduced in the 2017 Global INi tiatve for Asthma（GINA） update. However,Chinese medicine does not yet have a corresponding TCM disease name. In this article,through the preliminary discussion on the cause,pathogenesis,and disease name of A- CO,it is believed that the etiology and pathogenesis of the disease is characterized by repeated attacks of asthma,chronic lung disease,and the combined effects of various pathological factors,resulting in fullness and distension in the lung and failure of astringing and descending. By analyzing the corresponding names of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary overlap in ancient literatures,it is suggested that the overlap between asthma and chronic obstruetive pulmonary disease should be classified as ＂wheezing and distension＂.